<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642874</url>
  </required_header>
  <id_info>
    <org_study_id>methocarbamol</org_study_id>
    <nct_id>NCT02642874</nct_id>
  </id_info>
  <brief_title>Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients</brief_title>
  <official_title>Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly
      effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle
      spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the
      inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide
      range of safe and effective dosages.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly
      effective drug. Abrams et al compared patients with cirrhosis with those with congestive
      heart failure and found a significantly higher prevalence of weekly or daily cramps with
      cirrhosis (22%) vs patients with congestive heart failure (5%). Interestingly, there was no
      difference in diuretic use or dosing between the 2 groups, supporting that factors other than
      diuretic-mediated effects explained the differences. Methocarbamol is a central muscle
      relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is
      currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a
      high therapeutic index, i.e. a wide range of safe and effective dosages.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 22, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of muscle cramps</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Methocarbamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Methocarbamol twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Calcium carbonate twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methocarbamol</intervention_name>
    <description>Methocarbamol twice daily</description>
    <arm_group_label>Methocarbamol</arm_group_label>
    <other_name>Flexpro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium Carbonate</intervention_name>
    <description>Calcium carbonate twice daily</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>Calcitron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cirrhotic patients with frequent muscle cramps.

        Exclusion Criteria:

          -  Elderly patients.

          -  Encephalopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sherief M. Abd-Elsalam, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>liver diseases dept.- Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walaa A. Elkhalawany, Consultant</last_name>
    <role>Study Director</role>
    <affiliation>liver diseases dept.- Tanta university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sherief M. Abd-Elsalam, Consultant</last_name>
    <phone>00201095159522</phone>
    <email>sherif_tropical@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tanta university - faculty of medicine</name>
      <address>
        <city>Tanta</city>
        <state>Elgharbia</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2015</study_first_submitted>
  <study_first_submitted_qc>December 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>December 30, 2017</last_update_submitted>
  <last_update_submitted_qc>December 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Sherief Abd-Elsalam</investigator_full_name>
    <investigator_title>Consultant liver and GIT diseases- Tanta university hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
    <mesh_term>Methocarbamol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

